Brandtree

Vertex: brands it owns and its ownership tree

Vertex (NASDAQ: VRTX) is a publicly listed company headquartered in Boston, United States that owns 7 consumer brands.[1]

Vertex is a US biotechnology company based in Boston. Its 2025 Form 10-K reports sales of cystic fibrosis medicines, the sickle cell and thalassemia therapy Casgevy and the pain medicine Journavx.

Company facts

Legal name
Vertex Pharmaceuticals Incorporated
Type
publicly listed company · see all publicly listed company owners
Headquarters
🇺🇸 Boston, United States
Founded
1989
Tickers
NASDAQ: VRTX
SEC CIK
0000875320
Last verified
· 1 sources

Vertex in numbers

Vertex financial history

Headline figures from Vertex's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $6.21bn to $12bn, an average of 14.1% a year (calculated).

Fiscal year endedRevenueOperating incomeOperating marginNet incomeTotal assetsLong-term debtFiling
$12bn $4.17bn 34.8% $3.95bn $25.6bn — 10-K
$11bn $-232,900,000 -2.1% $-535,600,000 $22.5bn — 10-K
$9.87bn $3.83bn 38.8% $3.62bn $22.7bn — 10-K
$8.93bn $4.31bn 48.2% $3.32bn $18.2bn — 10-K
$7.57bn $2.78bn 36.7% $2.34bn $13.4bn — 10-K
$6.21bn $2.86bn 46.0% $2.71bn $11.8bn — 10-K

Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.

Everything Vertex owns

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Everything Vertex owns Tree of 7 brands under Vertex. Vertex Alyftrek Casgevy Journavx Kalydeco Orkambi Symdeko Trikafta

Full-screen interactive tree → · Download as infographic

Brand portfolio by category

Full portfolio, 7 brands, with sources →

Recent changes to this record

All changes →

Vertex in the global legal-entity registry

The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.

Legal entity identifier (LEI)
54930015RAQRRZ5ZGJ91
Registered name
VERTEX PHARMACEUTICALS INCORPORATED (US)
Registration status
Issued · record updated 20 May 2026
Parent
None named: it reports that no person or entity controls it.
Retrieved
· GLEIF record (JSON)

Vertex SEC filings

The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.

Annual reports

Proxy statements

Recent current and quarterly reports

FiledFormWhat it declares
8-KDeparture or appointment of directors or officers
10-QQuarterly report
8-KResults of operations and financial condition
8-KEntry into a material agreement; Regulation FD disclosure; Other events
8-KDeparture or appointment of directors or officers; Results of a shareholder vote
10-QQuarterly report
8-KResults of operations and financial condition
8-KDeparture or appointment of directors or officers
8-KOther events
8-KResults of operations and financial condition
10-QQuarterly report
8-KResults of operations and financial condition

Frequently asked questions

What brands does Vertex own?

Vertex owns 7 consumer brands tracked here, including Casgevy, Alyftrek, Journavx, Kalydeco, Trikafta and Orkambi.

Is Vertex an American company?

Yes. Vertex is headquartered in Boston, United States and was founded in 1989.

Who owns Vertex?

Vertex is a publicly listed company owned by its shareholders; it trades as VRTX on the NASDAQ.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Vertex Pharmaceuticals Incorporated Annual Report on Form 10-K filed 2026-02-13 — SEC EDGAR, SEC Form 10-K, published 13 February 2026; retrieved 17 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.